Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Subunit Vaccine
Revenue, means the sales value of Subunit Vaccine
This report studies Subunit Vaccine in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Astellas
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Johnson&Johnson
MedImmune
Merck
Serum Institute
Sanofi Pasteur
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by Application, this report focuses on consumption, market share and growth rate of Subunit Vaccine in each application, can be divided into
Application 1
Application 2
China Subunit Vaccine Market Research Report 2017
1 Subunit Vaccine Market Overview
1.1 Product Overview and Scope of Subunit Vaccine
1.2 Subunit Vaccine Segment by Type
1.2.1 China Production Market Share of Subunit Vaccine Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Applications of Subunit Vaccine
1.3.1 Subunit Vaccine Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 China Market Size (Value) of Subunit Vaccine (2012-2022)
1.5 China Subunit Vaccine Status and Outlook
1.6 Government Policies
2 China Subunit Vaccine Market Competition by Manufacturers
2.1 China Subunit Vaccine Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Subunit Vaccine Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Subunit Vaccine Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Subunit Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Subunit Vaccine Market Competitive Situation and Trends
2.5.1 Subunit Vaccine Market Concentration Rate
2.5.2 Subunit Vaccine Market Share of Top 3 and Top 5 Manufacturers
3 China Subunit Vaccine Manufacturers Profiles/Analysis
3.1 Astellas
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Subunit Vaccine Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Astellas Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 CSL Limited
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Subunit Vaccine Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 CSL Limited Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Emergent BioSolutions
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Subunit Vaccine Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Emergent BioSolutions Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Subunit Vaccine Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 GlaxoSmithKline Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Johnson&Johnson
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Subunit Vaccine Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Johnson&Johnson Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 MedImmune
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Subunit Vaccine Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 MedImmune Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Merck
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Subunit Vaccine Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Merck Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Serum Institute
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Subunit Vaccine Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Serum Institute Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Sanofi Pasteur
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Subunit Vaccine Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Sanofi Pasteur Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
4 China Subunit Vaccine Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Subunit Vaccine Capacity, Production and Growth (2012-2017)
4.2 China Subunit Vaccine Revenue and Growth (2012-2017)
4.3 China Subunit Vaccine Production, Consumption, Export and Import (2012-2017)
5 China Subunit Vaccine Production, Revenue (Value), Price Trend by Type
5.1 China Subunit Vaccine Production and Market Share by Type (2012-2017)
5.2 China Subunit Vaccine Revenue and Market Share by Type (2012-2017)
5.3 China Subunit Vaccine Price by Type (2012-2017)
5.4 China Subunit Vaccine Production Growth by Type (2012-2017)
6 China Subunit Vaccine Market Analysis by Application
6.1 China Subunit Vaccine Consumption and Market Share by Application (2012-2017)
6.2 China Subunit Vaccine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaSubunit Vaccine Market Analysis by Regions (Provinces)
7.1 China Subunit Vaccine Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Subunit Vaccine Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Subunit Vaccine Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Subunit Vaccine Sales Price by Regions (Provinces)(2012-2017)
7.2 China Subunit Vaccine Consumption by Regions (Provinces)(2012-2017)
7.3 China Subunit Vaccine Production, Consumption, Export and Import (2012-2017)
8 Subunit Vaccine Manufacturing Cost Analysis
8.1 Subunit Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Subunit Vaccine
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Subunit Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Subunit Vaccine Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Subunit Vaccine Market Forecast (2017-2022)
12.1 China Subunit Vaccine Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Subunit Vaccine Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Subunit Vaccine Production Forecast by Type (2017-2022)
12.4 China Subunit Vaccine Consumption Forecast by Application (2017-2022)
12.5 China Subunit Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Subunit Vaccine Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Subunit Vaccine Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Subunit Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Subunit Vaccine Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Subunit Vaccine
Figure China Production Market Share of Subunit Vaccine by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Subunit Vaccine Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Subunit Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table China Subunit Vaccine Capacity of Key Manufacturers (2015 and 2016)
Table China Subunit Vaccine Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Subunit Vaccine Capacity of Key Manufacturers in 2015
Figure China Subunit Vaccine Capacity of Key Manufacturers in 2016
Table China Subunit Vaccine Production of Key Manufacturers (2015 and 2016)
Table China Subunit Vaccine Production Share by Manufacturers (2015 and 2016)
Figure 2015 Subunit Vaccine Production Share by Manufacturers
Figure 2016 Subunit Vaccine Production Share by Manufacturers
Table China Subunit Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Subunit Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Subunit Vaccine Revenue Share by Manufacturers
Table 2016 China Subunit Vaccine Revenue Share by Manufacturers
Table China Market Subunit Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Subunit Vaccine Average Price of Key Manufacturers in 2015
Table Manufacturers Subunit Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Subunit Vaccine Product Type
Figure Subunit Vaccine Market Share of Top 3 Manufacturers
Figure Subunit Vaccine Market Share of Top 5 Manufacturers
Table Astellas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Subunit Vaccine Market Share (2012-2017)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Limited Subunit Vaccine Market Share (2012-2017)
Table Emergent BioSolutions Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent BioSolutions Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Emergent BioSolutions Subunit Vaccine Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Subunit Vaccine Market Share (2012-2017)
Table Johnson&Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson&Johnson Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson&Johnson Subunit Vaccine Market Share (2012-2017)
Table MedImmune Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MedImmune Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune Subunit Vaccine Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Subunit Vaccine Market Share (2012-2017)
Table Serum Institute Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Serum Institute Subunit Vaccine Market Share (2012-2017)
Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur Subunit Vaccine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Pasteur Subunit Vaccine Market Share (2012-2017)
Figure China Subunit Vaccine Capacity, Production and Growth (2012-2017)
Figure China Subunit Vaccine Revenue (Million USD) and Growth (2012-2017)
Table China Subunit Vaccine Production, Consumption, Export and Import (2012-2017)
Table China Subunit Vaccine Production by Type (2012-2017)
Table China Subunit Vaccine Production Share by Type (2012-2017)
Figure Production Market Share of Subunit Vaccine by Type (2012-2017)
Figure 2015 Production Market Share of Subunit Vaccine by Type
Table China Subunit Vaccine Revenue by Type (2012-2017)
Table China Subunit Vaccine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Subunit Vaccine by Type (2012-2017)
Figure 2015 Revenue Market Share of Subunit Vaccine by Type
Table China Subunit Vaccine Price by Type (2012-2017)
Figure China Subunit Vaccine Production Growth by Type (2012-2017)
Table China Subunit Vaccine Consumption by Application (2012-2017)
Table China Subunit Vaccine Consumption Market Share by Application (2012-2017)
Figure China Subunit Vaccine Consumption Market Share by Application in 2015
Table China Subunit Vaccine Consumption Growth Rate by Application (2012-2017)
Figure China Subunit Vaccine Consumption Growth Rate by Application (2012-2017)
Table China Subunit Vaccine Production by Regions (Provinces)(2012-2017)
Table China Subunit Vaccine Production Market Share by Regions (Provinces)(2012-2017)
Table China Subunit Vaccine Production Value by Regions (Provinces)(2012-2017)
Table China Subunit Vaccine Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Subunit Vaccine Sales Price by Regions (Provinces)(2012-2017)
Table China Subunit Vaccine Consumption by Regions (Provinces)(2012-2017)
Table China Subunit Vaccine Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Subunit Vaccine Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Subunit Vaccine
Figure Manufacturing Process Analysis of Subunit Vaccine
Figure Subunit Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Subunit Vaccine Major Manufacturers in 2015
Table Major Buyers of Subunit Vaccine
Table Distributors/Traders List
Figure China Subunit Vaccine Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Subunit Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table China Subunit Vaccine Production, Import, Export and Consumption Forecast (2017-2022)
Table China Subunit Vaccine Production Forecast by Type (2017-2022)
Table China Subunit Vaccine Consumption Forecast by Application (2017-2022)
Table China Subunit Vaccine Production Forecast by Regions (Provinces)(2017-2022)
Table China Subunit Vaccine Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Subunit Vaccine Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...